Quarterly report pursuant to Section 13 or 15(d)

Condensed Balance Sheets (Unaudited)

v3.22.1
Condensed Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Mar. 31, 2022
Dec. 31, 2021
Current assets:    
Cash and cash equivalents $ 28,901 $ 30,414
Marketable securities 142,500 130,343
Investment in equity securities 37,744 37,181
Accounts receivable 11,686 12,454
Prepaid expenses and other current assets 7,911 8,123
Total current assets 228,742 218,515
Property and equipment, net 23,285 22,550
Operating lease right-of-use assets 28,372 29,041
Marketable securities, non-current 20,699 68,775
Other non-current assets 1,705 1,655
Restricted cash 872 872
Total assets 303,675 341,408
Current liabilities:    
Accounts payable 10,705 11,327
Accrued compensation 5,408 11,417
Deferred revenue—current 6,279 5,496
Operating lease liability - current 1,078 1,037
Debt—current 12,500 9,375
Other current liabilities 2,790 3,084
Total current liabilities 38,760 41,736
Operating lease liability - non-current 31,634 31,224
Debt—non-current 12,762 15,738
Other noncurrent liabilities 147 146
Total liabilities 83,303 88,844
Stockholders’ equity:    
Preferred stock, $0.001 par value - 10,000,000 shares authorized as of March 31, 2022 and December 31, 2021; 0 shares issued and outstanding as of March 31, 2022 and December 31, 2021
Common stock, $0.001 par value - 300,000,000 shares authorized as of March 31, 2022 and December 31, 2021; 46,926,859 and 46,327,131 shares issued and outstanding as of March 31, 2022 and December 31, 2021, respectively 47 46
Additional paid-in-capital 593,998 586,243
Accumulated other comprehensive (loss) income (1,152) (314)
Accumulated deficit (372,521) (333,411)
Total stockholders’ equity 220,372 252,564
Total Liabilities and Stockholders’ Equity $ 303,675 $ 341,408